Plasmodium mutant and vaccines including the mutant
US7550138B1 · kind B1 · utility
11Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 14, 2007 |
| Grant date | Jun 23, 2009 |
| Priority date | — |
| Expiry date | Aug 14, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the production of new Plasmodium mutants which are defective in the expression of the protein P36p. These mutants are unable to cause malaria, yet they can be used as vaccine, giving long lasting protection against infections with wild-type Plasmodium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.